Position in LEGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,286,813
-$312,402 QoQ
Shares Held
71,134
-3.3% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in LEGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,286,813 | 71,134 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,599,215 | 73,561 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $2,060,657 | 63,191 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $2,154,703 | 60,713 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $10,291,986 | 303,330 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,663,188 | 266,232 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $11,364,224 | 233,208 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $10,567,594 | 238,600 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $840,620 | 14,987 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||